What is the address of DOCTEUR CHARLOTTE GRANDJEAN?

The registered office of DOCTEUR CHARLOTTE GRANDJEAN is located at Avenue Bel Horizon 58, 1341 Ottignies-Louvain-la-Neuve.

Is DOCTEUR CHARLOTTE GRANDJEAN still active?

Yes. According to the CBE (19 September 2026) DOCTEUR CHARLOTTE GRANDJEAN is active, legal situation “Normale toestand”, started on 20 December 2019.

Is DOCTEUR CHARLOTTE GRANDJEAN registered on Peppol?

No, DOCTEUR CHARLOTTE GRANDJEAN is currently not registered on the Peppol network.

What is the enterprise number of DOCTEUR CHARLOTTE GRANDJEAN?

The enterprise number of DOCTEUR CHARLOTTE GRANDJEAN is BE0739913327.

When was DOCTEUR CHARLOTTE GRANDJEAN founded?

DOCTEUR CHARLOTTE GRANDJEAN was founded on 20 December 2019.

Who are the directors of DOCTEUR CHARLOTTE GRANDJEAN?

According to the 2025 annual accounts, the directors of DOCTEUR CHARLOTTE GRANDJEAN are: Charlotte Grandjean.

Is DOCTEUR CHARLOTTE GRANDJEAN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 December 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOCTEUR CHARLOTTE GRANDJEAN make in 2025?

DOCTEUR CHARLOTTE GRANDJEAN posted a profit after taxes of € 151,252 in financial year 2025.

What is the revenue of DOCTEUR CHARLOTTE GRANDJEAN?

As a small company, DOCTEUR CHARLOTTE GRANDJEAN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 197,318.

DOCTEUR CHARLOTTE GRANDJEAN (Private Limited)

Dossier DOCTEUR CHARLOTTE GRANDJEAN, printed on 19 September 2026 from databakkes.be/en/0739913327/docteur-charlotte-grandjean. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DOCTEUR CHARLOTTE GRANDJEAN from Ottignies-Louvain-la-Neuve, company number BE0739913327, closed financial year 2025 with a result of € 151,252 after tax. For that financial year DOCTEUR CHARLOTTE GRANDJEAN recorded a gross margin of € 197,318 and equity of € 3,047. Compared with financial year 2024, the result moved from € 144,052 to € 151,252. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.

What it is worth Healthy

€ 3,047

▼ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 151,252

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 132,872

▼ 11% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 151,400 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,228

▲ 239% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 32

▼ 99% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 141,960 Gross margin 2022: € 141,960 First fiscal year in the series	€ 150,506 Gross margin 2023: € 150,506 ▲ 6% vs 2022 (€ 141,960) Favourable step	€ 189,266 Gross margin 2024: € 189,266 ▲ 26% vs 2023 (€ 150,506) Favourable step	€ 197,318 Gross margin 2025: € 197,318 ▲ 4% vs 2024 (€ 189,266) Favourable step	▲ 4%
Profit after taxes	€ 109,580 Profit after taxes 2022: € 109,580 First fiscal year in the series	€ 116,340 Profit after taxes 2023: € 116,340 ▲ 6% vs 2022 (€ 109,580) Favourable step	€ 144,052 Profit after taxes 2024: € 144,052 ▲ 24% vs 2023 (€ 116,340) Favourable step	€ 151,252 Profit after taxes 2025: € 151,252 ▲ 5% vs 2024 (€ 144,052) Favourable step	▲ 5%
Equity	€ 3,303 Equity 2022: € 3,303 First fiscal year in the series	€ 3,644 Equity 2023: € 3,644 ▲ 10% vs 2022 (€ 3,303) Favourable step	€ 3,196 Equity 2024: € 3,196 ▼ 12% vs 2023 (€ 3,644) Unfavourable step	€ 3,047 Equity 2025: € 3,047 ▼ 5% vs 2024 (€ 3,196) Unfavourable step	▼ 5%
Total debts	€ 353,788 Total debts 2022: € 353,788 First fiscal year in the series	€ 132,389 Total debts 2023: € 132,389 ▼ 63% vs 2022 (€ 353,788) Favourable step	€ 162,637 Total debts 2024: € 162,637 ▲ 23% vs 2023 (€ 132,389) Unfavourable step	€ 146,337 Total debts 2025: € 146,337 ▼ 10% vs 2024 (€ 162,637) Favourable step	▼ 10%
Cash	€ 343,738 Cash 2022: € 343,738 First fiscal year in the series	€ 121,767 Cash 2023: € 121,767 ▼ 65% vs 2022 (€ 343,738) Unfavourable step	€ 149,045 Cash 2024: € 149,045 ▲ 22% vs 2023 (€ 121,767) Favourable step	€ 132,872 Cash 2025: € 132,872 ▼ 11% vs 2024 (€ 149,045) Unfavourable step	▼ 11%
Retained profit	€ 303 Retained profit 2022: € 303 First fiscal year in the series	€ 644 Retained profit 2023: € 644 ▲ 112% vs 2022 (€ 303) Favourable step	€ 196 Retained profit 2024: € 196 ▼ 70% vs 2023 (€ 644) Unfavourable step	€ 47 Retained profit 2025: € 47 ▼ 76% vs 2024 (€ 196) Unfavourable step	▼ 76%
Dividend	€ 308,000 Dividend 2022: € 308,000 First fiscal year in the series	€ 116,000 Dividend 2023: € 116,000 ▼ 62% vs 2022 (€ 308,000) Unchanged	€ 144,500 Dividend 2024: € 144,500 ▲ 25% vs 2023 (€ 116,000) Unchanged	€ 151,400 Dividend 2025: € 151,400 ▲ 5% vs 2024 (€ 144,500) Unchanged	▲ 5%
Balance sheet total	€ 357,091 Balance sheet total 2022: € 357,091 First fiscal year in the series	€ 136,033 Balance sheet total 2023: € 136,033 ▼ 62% vs 2022 (€ 357,091) Unchanged	€ 165,833 Balance sheet total 2024: € 165,833 ▲ 22% vs 2023 (€ 136,033) Unchanged	€ 149,385 Balance sheet total 2025: € 149,385 ▼ 10% vs 2024 (€ 165,833) Unchanged	▼ 10%

Key figures of DOCTEUR CHARLOTTE GRANDJEAN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOCTEUR CHARLOTTE GRANDJEAN?

What happened at DOCTEUR CHARLOTTE GRANDJEAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 19, 2026 New annual accounts for financial year 2025: profit of € 151,252 (▲ 5% vs 2024). Source: NBB ↗
Dec 20, 2019 New establishment in Ottignies-Louvain-la-Neuve. KBO
Dec 20, 2019 Start of the company according to the CBE. KBO

In short

From € 109,580 profit in 2022 to € 151,252 profit in 2025.

Paid € 152,932 in corporate taxes since 2022.

Best year ever: 2025, with € 151,252 profit.

Paid out € 719,900 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOCTEUR CHARLOTTE GRANDJEAN? We notify you, reason included.

Follow DOCTEUR CHARLOTTE GRANDJEAN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Charlotte Grandjean

DOCTEUR CHARLOTTE GRANDJEAN

Behind DOCTEUR CHARLOTTE GRANDJEAN is Charlotte Grandjean.

See the full network in the app

Directors

According to the 2025 annual accounts

Charlotte Grandjean

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Bel Horizon 58

1341 Ottignies-Louvain-la-Neuve

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0739.913.327
VAT number: BE 0739.913.327
Registered office: Avenue Bel Horizon 58, 1341 Ottignies-Louvain-la-Neuve
Names & denominations: DOCTEUR CHARLOTTE GRANDJEAN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 December 2019
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗